Free Trial
OTCMKTS:ACUR

Acura Pharmaceuticals (ACUR) Stock Price, News & Analysis

$0.03
0.00 (0.00%)
(As of 06/20/2024 ET)
Today's Range
$0.03
$0.03
50-Day Range
$0.00
$0.03
52-Week Range
$0.00
$0.05
Volume
80 shs
Average Volume
590 shs
Market Capitalization
$1.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ACUR stock logo

About Acura Pharmaceuticals Stock (OTCMKTS:ACUR)

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.

ACUR Stock Price History

ACUR Stock News Headlines

Who are Nvidia’s Silent Partners?
Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.
Who are Nvidia’s Silent Partners?
Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.
Acura Pharmaceuticals Inc ACUR
Acura Pharmaceuticals, Inc. (ACUR)
ACUR - Acura Pharmaceuticals, Inc.
Azilsartan Medoxomil API Market Forecast to 2030
4 Stocks Under $10 Moving Higher
Opioid Drugs Market Sales By 2030
Acura Stock Soars (ACUR)
See More Headlines
Receive ACUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2020
Today
6/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:ACUR
Previous Symbol
NASDAQ:ACUR
CUSIP
00509L70
Employees
9
Year Founded
1935

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.56 million

Miscellaneous

Free Float
52,947,000
Market Cap
$1.82 million
Optionable
Not Optionable
Beta
1.05

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Robert B. Jones (Age 65)
    CEO, President & Director
    Comp: $150k
  • Mr. Peter A. Clemens (Age 71)
    Senior VP, CFO & Secretary
    Comp: $200k
  • Mr. Robert A. Seiser CPA (Age 60)
    Ph.D., VP, Treasurer & Corporate Controller
    Comp: $210.2k

ACUR Stock Analysis - Frequently Asked Questions

How have ACUR shares performed in 2024?

Acura Pharmaceuticals' stock was trading at $0.0001 on January 1st, 2024. Since then, ACUR shares have increased by 27,400.0% and is now trading at $0.0275.
View the best growth stocks for 2024 here
.

How were Acura Pharmaceuticals' earnings last quarter?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) released its earnings results on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 EPS for the quarter. The specialty pharmaceutical company earned $1.32 million during the quarter.

What other stocks do shareholders of Acura Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acura Pharmaceuticals investors own include Denali Therapeutics (DNLI), Adamis Pharmaceuticals (ADMP), Ekso Bionics (EKSO), VIVUS (VVUS), Fulcrum Therapeutics (FULC), (GBSN) (GBSN), Trevena (TRVN), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA) and Advanced Micro Devices (AMD).

How do I buy shares of Acura Pharmaceuticals?

Shares of ACUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Acura Pharmaceuticals have any subsidiaries?
The following companies are subsidiares of Acura Pharmaceuticals: Acura Pharmaceutical Technologies Inc..
Read More
This page (OTCMKTS:ACUR) was last updated on 6/21/2024 by MarketBeat.com Staff

From Our Partners